Advances in understanding newer autoantibodies and their role as biomarkers in systemic lupus erythematosus

Bibliography

• SHERER Y, GORSTEIN A, FRITZLER MJ, SHOENFELD Y: Autoantibody explosion in systemic lupus erythematosus. Semin. Arthritis Rheum. (2004) 34:501-537.
   PubMed Web of Science ®Google Scholar
• SHERER Y, SHOENFELD Y: Autoantibody explosion in lupus – 155 different autoantibodies in SLE. Lupus (2007) 16(Suppl.):42.
   Web of Science ®Google Scholar
• WALKER JG, BARNABE C, FRITZLER MJ: Autoantibodies, classification criteria and diagnosis of systemic autoimmune rheumatic diseases. In: From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Conrad K, Chan EKL, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A (Eds), Pabst Science Publishers, Lengerich, Germany (2007):352-369.
   Google Scholar
• ARBUCKLE MR, MCCLAIN MT, RUBERTONE MV et al.: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. (2003) 349:1526-1533.
   PubMed Web of Science ®Google Scholar
• MCCLAIN MT, ARBUCKLE MR, HEINLEN LD et al.: The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum. (2004) 50:1226-1232.
   PubMed Web of Science ®Google Scholar
• HEINLEN LD, MCCLAIN MT, MERRILL J et al.: Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum. (2007) 56:2344-2351.
   PubMed Web of Science ®Google Scholar
• BIZZARO N, TOZZOLI R, SHOENFELD Y: Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum. (2007) 56:1736-1744.
   PubMed Web of Science ®Google Scholar
• CONRAD K, SCHLöSSER W, FRITZLER MJ: The predictive relevance of autoantibodies. In: From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Conrad K, Chan EKL, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A (Eds), Pabst Scientific Publishers, Lengerich, Germany (2007):16-31.
   Google Scholar
• RAMOS PS, KELLY JA, GRAY-MCGUIRE C et al.: Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus. Genes Immun. (2006) 7(5):417-432.
   PubMed Web of Science ®Google Scholar
• WANDSTRAT AE, CARR-JOHNSON F, BRANCH V et al.: Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J. Autoimmun. (2006) 27:153-160.
   PubMed Web of Science ®Google Scholar
• STINTON LM, BARR SG, TIBBLES LA et al.: Autoantibodies in lupus nephritis patients requiring renal transplantation. Lupus (2007) 16:394-400.
   PubMed Web of Science ®Google Scholar
• KOUTOUZOV S, JERONIMO AL, CAMPOS H, AMOURA Z: Nucleosomes in the pathogenesis of systemic lupus erythematosus. Rheum. Dis. Clin. North Am. (2004) 30:529-558.
   PubMed Web of Science ®Google Scholar
• SHOENFELD Y, TOUBI E: Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis Rheum. (2005) 52:2599-2606.
   PubMed Web of Science ®Google Scholar
• LI QZ, ZHOU J, WANDSTRAT AE et al.: Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin. Exp. Immunol. (2007) 147:60-70.
   PubMed Web of Science ®Google Scholar
• WERWITZKE S, TRICK D, KAMINO K et al.: Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB × NZW)F1 mouse. Arthritis Rheum. (2005) 52:3629-3638.
   PubMed Web of Science ®Google Scholar
• BISSONNETTE L, BERGERON MG: Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine. Expert Rev. Mol. Diagn. (2006) 6:433-450.
   PubMed Web of Science ®Google Scholar
• HOOPER JW: The genetic map to theranostics. MLO Med. Lab. Obs. (2006) 38:22-23, 25.
   PubMedGoogle Scholar
• UTZ PJ, GENSLER TJ, ANDERSON P: Death, autoantigen modifications, and tolerance. Arthritis Res. (2000) 2:101-114.
   PubMedGoogle Scholar
• KUECHLE MK, ELKON KB: Shining light on lupus and UV. Arthritis Res. Ther. (2007) 9:101.
   PubMed Web of Science ®Google Scholar
• KAPSOGEORGOU EK, BU-HELU RF, MOUTSOPOULOS HM, MANOUSSAKIS MN: Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum. (2005) 52:1517-1521.
   PubMed Web of Science ®Google Scholar
• CRAFT J, HARDIN JA: Linked sets of antinuclear antibodies: what do they mean? J. Rheumatol. (1987) 14(Suppl.):106-109.
   Web of Science ®Google Scholar
• THEOFILOPOULOS AN: The basis of autoimmunity. Part I. Mechanisms of abberant self-recognition. Immunol. Today (1995) 16:90-98.
   PubMedGoogle Scholar
• REICHLIN M: Molecular definition of the Ro(SSA) particle(s): a frequent target of autoimmunity in systemic lupus erythematosus and Sjogren's syndrome. Br. J. Rheumatol. (1991) 30:58-62.
   PubMedGoogle Scholar
• VON MUHLEN CA, TAN EM: Autoantibodies in the diagnosis of systemic rheumatic disease. Semin. Arthritis Rheum. (1995) 24:323-358.
   PubMed Web of Science ®Google Scholar
• TAN EM: Autoantibodies in diagnosis and identifying autoantigens. Immunologist (1999) 7:85-92.
   Google Scholar
• RUBIN RL, FRITZLER MJ: Antibodies to histones and nucleosome-related antigens. In: Dubois' Lupus Erythematosus. Wallace DJ, Hahn BH (Eds), Lippincott, Williams & Wilkins, Philadelphia, USA (2007):464-486.
   Google Scholar
• FRITZLER MJ, WIIK A, TAN EM et al.: A critical evaluation of enzyme immunoassay kits for detection of antinuclear antibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J. Rheumatol. (2003) 30:2374-2381.
   PubMed Web of Science ®Google Scholar
• WIIK AS, GORDON TP, KAVANAUGH AF et al.: Cutting edge diagnostics in rheumatology: on the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Care Res. (2004) 51:291-298.
   Web of Science ®Google Scholar
• FRITZLER MJ, WIIK A, FRITZLER ML, BARR SG: The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res. Ther. (2003) 5:192-201.
   PubMed Web of Science ®Google Scholar
• STINTON LM, EYSTATHIOY T, SELAK S, CHAN EKL, FRITZLER MJ: Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, golgi complex, proteasomes, assemblyosomes, exosomes and GW bodies. Clin. Immunol. (2004) 110:30-44.
   PubMed Web of Science ®Google Scholar
• SELAK S, SCHOENROTH L, SENÉCAL J-L, FRITZLER MJ: Early endosome antigen 1: an autoantigen associated with neurological diseases. J. Invest. Med. (1999) 47:311-318.
   PubMed Web of Science ®Google Scholar
• SELAK S, MAHLER M, MIYACHI K, FRITZLER ML, FRITZLER MJ: Identification of the B-cell epitopes of the early endosome antigen 1 (EEA1). Clin. Immunol. (2003) 109:154-164.
   PubMed Web of Science ®Google Scholar
• MAHLER M, KESSENBROCK K, RAATS J, WILLIAMS RCJR, FRITZLER MJ: Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins. J. Mol. Med. (2003) 81:194-204.
   PubMed Web of Science ®Google Scholar
• MAHLER M, KESSENBROCK K, RAATS J, FRITZLER MJ: Technical and clinical evaluation of anti-ribosomal P protein immunoassays. J. Clin. Lab. Anal. (2004) 18:215-223.
   PubMed Web of Science ®Google Scholar
• GRIFFITH KJ, RYAN JP, SENÉCAL J-L, FRITZLER MJ: The cytoplasmic linker protein CLIP-170 is a human autoantigen. Clin. Exp. Immunol. (2002) 127:533-538.
   PubMed Web of Science ®Google Scholar
• EYSTATHIOY T, CHAN EKL, YANG Z et al.: Clinical and serological associations of autoantibodies to a novel cytoplasmic autoantigen, GW182 and GW bodies. J. Mol. Med. (2003) 81:811-818.
   PubMed Web of Science ®Google Scholar
• BHANJI R, EYSTATHIOY T, CHAN EKL, BLOCH DB, FRITZLER MJ: Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin. Immunol. (2007) (In Press).
   PubMedGoogle Scholar
• FRITZLER MJ, MCCARTY GA, RYAN JP, KINSELLA TD: Clinical features of patients with antibodies directed against proliferating cell nuclear antigen (PCNA). Arthritis Rheum. (1983) 26:140-145.
   PubMed Web of Science ®Google Scholar
• ASERO R, ORIGGI L, CRESPI S, BERTETTI E, D'AGOSTINO P, RIBOLDI P: Autoantibody to proliferating cell nuclear antigen (PCNA) in SLE: a clinical and serological study. Clin. Exp. Rheumatol. (1987) 5:241-246.
   PubMed Web of Science ®Google Scholar
• KANEDA K, TAKASAKI Y, TAKEUCHI K et al.: Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases. J. Rheumatol. (2004) 31:2142-2150.
   PubMed Web of Science ®Google Scholar
• STELZL U, WORM U, LALOWSKI M et al.: A human protein–protein interaction network: a resource for annotating the proteome. Cell (2005) 122:957-968.
   PubMed Web of Science ®Google Scholar
• CUSICK ME, KLITGORD N, VIDAL M, HILL DE: Interactome: gateway into systems biology. Hum. Mol. Genet. (2005) 14(2):R171-R181.
   Web of Science ®Google Scholar
• BEN-CHETRIT E, CHAN EKL, SULLIVAN KF, TAN EM: A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J. Exp. Med. (1988) 167:1560-1571.
   PubMed Web of Science ®Google Scholar
• CHAN EKL, ANDRADE LEC: Antinuclear antibodies in Sjögren's syndrome. Rheum. Dis. Clin. North Am. (1992) 18:551-570.
   PubMed Web of Science ®Google Scholar
• BUYON JP, SLADE SG, REVEILLE JD, HAMEL JC, CHAN EKL: Autoantibody responses to the “native” 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjögren's syndrome. J. Immunol. (1994) 152:3675-3684.
   PubMed Web of Science ®Google Scholar
• NOZAWA K, FRITZLER MJ, VON MÜHLEN CA, CHAN EKL: Giantin is the major golgi autoantigen in human anti-golgi complex sera. Arthritis Res. Ther. (2004) 6:R95-R102.
   PubMed Web of Science ®Google Scholar
• RUTJES SA, VREE EGBERTS WT, JONGEN PH, PRUIJN G, VAN VENROOIJ JV: Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin. Exp. Immunol. (1997) 109:32-40.
   PubMed Web of Science ®Google Scholar
• FRANK MB, MCCUBBIN V, TRIEU E, WU Y, ISENBERG DA, TARGOFF IN: The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J. Autoimmun. (1999) 12:137-142.
   PubMed Web of Science ®Google Scholar
• PEENE I, MEHEUS L, DE KS, HUMBEL R, VEYS EM, DE KF: Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann. Rheum. Dis. (2002) 61:929-933.
   PubMed Web of Science ®Google Scholar
• HUEBER W, UTZ P, STEINMAN L, ROBINSON W: Autoantibody profiling for the study and treatment of autoimmune disease. Arthritis Res. (2002) 4:290-295.
   PubMedGoogle Scholar
• SCUSSEL-LONZETTI L, JOYAL F, RAYNAULD JP et al.: Predicting mortality in systemic sclerosis – analysis of a cohort of 309 french canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) (2002) 81:154-167.
   PubMed Web of Science ®Google Scholar
• FRITZLER MJ, SCHOENROTH LJ: Advances in understanding and use of autoantibodies as markers of diseases. In: Treatment of Autoimmune Diseases. Sticherling M, Christophers E (Eds), Springer-Verlag, Vienna, Austria (2003):29-42.
   Google Scholar
• FRITZLER MJ: New technologies in the detection of autoantibodies. In: Autoantigens, Autoantibodies, Autoimmunity. Conrad K, Fritzler MJ, Meurer M, Sack U, Shoenfeld Y (Eds), Pabst Scientific Publishers, Lengerich, Germany (2002):50-63.
   Google Scholar
• ROBINSON WH, STEINMAN L, UTZ PJ: Proteomics technologies for the study of autoimmune disease. Arthritis Rheum. (2002) 46:885-893.
   PubMed Web of Science ®Google Scholar
• UTZ PJ: 21st European workshop for rheumatology research, Vienna, Austria, (1 – 4 March 2001) Arthritis Res. (2001) 3:237-240.
   PubMedGoogle Scholar
• Yamasaki Y, Narain S, Yoshida H et al.: Autoantibodies to RNA helicase A: a new serologic marker of early lupus. Arthritis Rheum. (2007) 56:596-604.
   PubMed Web of Science ®Google Scholar
• TAKEDA Y, CAUDELL P, GRADY G et al.: Human RNA helicase A is a lupus autoantigen that is cleaved during apoptosis. J. Immunol. (1999) 163:6269-6274.
   PubMed Web of Science ®Google Scholar
• YOSHIDA H, SATOH M, BEHNEY KM et al.: Effect of an exogenous trigger on the pathogenesis of lupus in (NZB × NZW)F1 mice. Arthritis Rheum. (2002) 46:2235-2244.
   PubMed Web of Science ®Google Scholar
• SATOH M, MIZUTANI A, BEHNEY KM et al.: X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus. Int. Immunol. (2003) 15:1117-1124.
   PubMed Web of Science ®Google Scholar
• MIYACHI K, FRITZLER MJ, TAN EM: Autoantibody to a nuclear antigen in proliferating cells. J. Immunol. (1978) 121:2228-2234.
   PubMed Web of Science ®Google Scholar
• HAHN BH: Overview of pathogenesis of systemic lupus erythematosus. In: Dubois' Lupus Erythematosus. Wallace DJ, Hahn BH (Eds), Lippincott Williams & Wilkins, Philadelphia, USA (2007):46-53.
   Google Scholar
• COHEN AS, REYNOLDS WE, FRANKLIN EC et al.: Preliminary criteria for the classification of systemic lupus erythematosus. Bull. Rheum. Dis. (1971) 21:643-648.
   Google Scholar
• TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. (1982) 25:1271-1277.
   PubMed Web of Science ®Google Scholar
• HOCHBERG MC: Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. (1997) 40:1725.
   PubMed Web of Science ®Google Scholar
• ULVESTAD E, KANSETROM A, MADLAND TM, THOMASSE E, HAGA HJ, VOLLSET SE: Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scand. J. Immunol. (2000) 52:309-315.
   PubMed Web of Science ®Google Scholar
• PRASAD R, IBANEZ D, GLADMAN D, UROWITZ M: Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus. Lupus (2006) 15:285-291.
   PubMed Web of Science ®Google Scholar
• MIYAKIS S, LOCKSHIN MD, ATSUMI T et al.: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. (2006) 4:295-306.
   PubMed Web of Science ®Google Scholar
• HARGRAVES MM, RICHMOND H, MORTON R: Presentation of two bone marrow elements: the “tart” cells and the “L.E.” cell. Mayo Clin. Proc. (1948) 27:25-28.
   Google Scholar
• FRITZLER MJ, FRITZLER ML: The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr. Med. Chem. (2006) 13:2503-2512.
   PubMed Web of Science ®Google Scholar
• TAN EM, SMOLEN J, MCDOUGAL JS et al.: A critical evaluation of enzyme immunoassays for the detection of antinuclear antibodies of defined specificities. I. Precision, sensitivity and specificity. Arthritis Rheum. (1999) 42:455-464.
   PubMed Web of Science ®Google Scholar
• FRITZLER MJ, WIIK A: Autoantibody assays, testing, and standardization. In: The Autoimmune Diseases. Rose NR, Mackay IR (Eds), Elsevier Academic Press, Sydney, Australia (2006):1011-1122.
   Google Scholar
• REKVIG OP, KALAAJI M, NOSSENT H: Anti-DNA antibody subpopulations and lupus nephritis. Autoimmun. Rev. (2004) 3:1-6.
   PubMedGoogle Scholar
• AARDEN LA, DE GROOT ER, FELTKAMP TE: Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann. NY Acad. Sci. (1975) 254:505-515.
   PubMed Web of Science ®Google Scholar
• KURIEN BT, SCOFIELD RH: Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand. J. Immunol. (2006) 64:227-235.
   PubMed Web of Science ®Google Scholar
• MAHLER M, FRITZLER MJ: Anti-dsDNA antibody testing in the clinic: farr or ELISA? Nat. Clin. Pract. Rheumatol. (2007) 3:72-73.
   PubMedGoogle Scholar
• DAMOISEAUX J, BOESTEN K, GIESEN J, AUSTEN J, TERVAERT JW: Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann. NY Acad. Sci. (2005) 1050:340-347.
   PubMed Web of Science ®Google Scholar
• FRITZLER MJ: Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus (2006) 15:422-427.
   PubMed Web of Science ®Google Scholar
• MIGLIORINI P, BALDINI C, ROCCHI V, BOMBARDIERI S: Anti-Sm and anti-RNP antibodies. Autoimmunity (2005) 38:47-54.
   PubMed Web of Science ®Google Scholar
• JANWITYANUCHIT S, VERASERTNIYOM O, VANICHAPUNTU M, VATANASUK M: Anti-Sm: its predictive value in systemic lupus erythematosus. Clin. Rheumatol. (1993) 12:350-353.
   PubMed Web of Science ®Google Scholar
• MAHLER M, FRITZLER MJ, BLUTHNER M: Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies. Arthritis Res. Ther. (2005) 7:R19-R29.
   PubMed Web of Science ®Google Scholar
• MAHLER M, STINTON LM, FRITZLER MJ: Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of an SmD3 peptide-based immunoassay. Clin. Diagn. Lab. Immunol. (2005) 12:107-113.
   PubMedGoogle Scholar
• ELKON KB, PARNASSA AP, FOSTER CL: Lupus autoantibodies target ribosomal P proteins. J. Exp. Med. (1985) 162:459-572.
   PubMed Web of Science ®Google Scholar
• MAHLER M, KESSENBROCK K, SZMYRKA M et al.: International multicenter evaluation of autoantibodies to ribosomal P proteins. Clin. Vaccine Immunol. (2006) 13:77-83.
   PubMed Web of Science ®Google Scholar
• LEPAGE SH, DUDENEY C, SHALL S, SHOENFELD Y, ISENBERG DA: Disease specificity of antibodies to poly (ADP-ribose); their relationships to anti-DNA antibodies and disease activity in lupus. Autoimmunity (2002) 5:167-177.
   Google Scholar
• GHIRARDELLO A, DORIA A, ZAMPIERI S, GERLI R, RAPIZZI E, GAMBARI PF: Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann. Rheum. Dis. (2000) 59:975-981.
   PubMed Web of Science ®Google Scholar
• GERLI R, CAPONI L: Anti-ribosomal P protein antibodies. Autoimmunity (2005) 38:85-92.
   PubMed Web of Science ®Google Scholar
• MAHLER M, RAIJMAKERS R, FRITZLER MJ: Challenges and controversies associated with systemic rheuamtic diseases. Curr. Rheumatol. Rev. (2007) (In Press).
   Google Scholar
• PRESS J, PALAYEW K, LAXER RM et al.: Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis Rheum. (1996) 39:671-676.
   PubMedGoogle Scholar
• ELKON KB, BONFA E, LLOVET R, EISENBERG RA: Association between anti-Sm and anti-ribosomal P protein autoantibodies in human systemic lupus erythematosus and MRL/lpr mice. J. Immunol. (1989) 143:1549-1554.
   PubMed Web of Science ®Google Scholar
• REICHLIN M, WOLFSON-REICHLIN M: Correlations of anti-dsDNA and anti-ribosomal P autoantibodies with lupus nephritis. Clin. Immunol. (2003) 108:69-72.
   PubMed Web of Science ®Google Scholar
• NOJIMA Y, MINOTA S, YAMADA A, TAKAKU F: Identification of an acidic ribosomal protein reactive with anti-Sm autoantibody. J. Immunol. (1989) 143:1915-1920.
   PubMed Web of Science ®Google Scholar
• KESSENBROCK K, FRITZLER MJ, GROVES M et al.: Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection. J. Mol. Med. (2007) 85(9):953-959.
   PubMed Web of Science ®Google Scholar
• LEVITUS G, HONTEBEYRIE-JOSKOWICZ M, VAN REGENMORTEL MHV, LEVIN MJ: Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. Clin. Exp. Immunol. (1991) 85:413-417.
   PubMed Web of Science ®Google Scholar
• STEINBERG AD: Concepts of pathogenesis of systemic lupus erythematosus. Clin. Immunol. Immunopathol. (1992) 631:19-22.
   Google Scholar
• SUER W, DAHNRICH C, SCHLUMBERGER W, STOCKER W: Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes. J. Autoimmun. (2004) 22:325-334.
   PubMed Web of Science ®Google Scholar
• GOMEZ-PUERTA JA, BURLINGAME RW, CERVERA R: Anti-chromatin (anti-nucleosome) antibodies. Lupus (2006) 15:408-411.
   PubMed Web of Science ®Google Scholar
• NG KP, MANSON JJ, RAHMAN A, ISENBERG DA: Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum. (2006) 55:900-904.
   PubMed Web of Science ®Google Scholar
• DEGIORGIO LA, KONSTANTINOV KN, LEE SC, HARDIN JA, VOLPE BT, DIAMOND B: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. (2001) 7:1189-1193.
   PubMed Web of Science ®Google Scholar
• KOWAL C, DEGIORGIO LA, LEE JY et al.: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. USA (2006) 103:19854-19859.
   PubMed Web of Science ®Google Scholar
• MU FT, CALLAGHAN JM, STEELE-MORTIMER HS et al.: EEA1, an early endosomal protein. J. Biol. Chem. (1995) 270:13503-13511.
   PubMed Web of Science ®Google Scholar
• WAITE RL, SENTRY JW, STENMARK H, TOH BH: Autoantibodies to a novel early endosome antigen 1. Clin. Immunol. Immunopathol. (1998) 86:81-87.
   PubMedGoogle Scholar
• SELAK S, FRITZLER MJ: Altered neurological function in mice immunized with early endosome antigen 1. BMC Neurosci. (2004) 5:2.
   PubMedGoogle Scholar
• SELAK S, PATERNAIN AV, FRITZLER MJ, LERMA J: Human autoantibodies against early endosome antigen-1 enhance excitatory synaptic transmission. Neuroscience (2006) 143:953-964.
   PubMed Web of Science ®Google Scholar
• GAYNOR B, PUTTERMAN C, VALADON P, SPATZ L, SCHARFF MD, DIAMOND B: Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc. Natl. Acad. Sci. USA (1997) 94:1955-1960.
   PubMed Web of Science ®Google Scholar
• PUTTERMAN C, DIAMOND B: Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J. Exp. Med. (1998) 188:29-38.
   PubMed Web of Science ®Google Scholar
• LAFER EM, RAUCH J, ANDRZEJEWSKI C Jr et al.: Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J. Exp. Med. (1981) 153:897-909.
   PubMed Web of Science ®Google Scholar
• SHOENFELD Y, RAUCH J, MASSICOTTE H et al.: Polyspecificity of monoclonal lupus autoantibodies produced by human–human hybridomas. N. Engl. J. Med. (1983) 308:414-420.
   PubMed Web of Science ®Google Scholar
• OMDAL R, BROCKSTAD K, WATERLOO K, KOLDINGSNES W, JONNSON R, MELLGREN SI: Neuropsychiatric disturbances in SLE are assocaited with antibodies against NMDA receptors. Eur. J. Neurol. (2005) 12:392-398.
   PubMed Web of Science ®Google Scholar
• HANLY JG, UROWITZ MB, SANCHEZ-GUERRERO J et al.: Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum. (2006) 56:265-273.
   Web of Science ®Google Scholar
• LAPTEVA L, NOWAK M, YARBORO CH et al.: Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. (2006) 54:2505-2514.
   PubMed Web of Science ®Google Scholar
• HARRISON MJ, RAVDIN LD, LOCKSHIN MD: Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum. (2006) 54:2515-2522.
   PubMed Web of Science ®Google Scholar
• MANIATAKI E, DE PS, MOURELATOS Z: Immunoprecipitation of microRNPs and directional cloning of microRNAs. Methods Mol. Biol. (2005) 309:283-294.
   PubMedGoogle Scholar
• STEUP-BEEKMAN G, STEENS S, VAN BM, HUIZINGA T: Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives. Lupus (2007) 16:329-334.
   PubMed Web of Science ®Google Scholar
• ELKON K, SKELLY S, PATNASSA A et al.: The identification and synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA (1986) 83:7419-7423.
   PubMed Web of Science ®Google Scholar
• BONFA E, ELKON KB: Clinical and serologic associations of the antiribosomal protein antibody. Arthritis Rheum. (1986) 29:981-985.
   PubMed Web of Science ®Google Scholar
• KATZAV A, SOLODEEV I, BRODSKY O et al.: Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. (2007) 56:938-948.
   PubMed Web of Science ®Google Scholar
• SHOENFELD Y: To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system. J. Autoimmun. (2007) 28(2-3):165-169.
   PubMed Web of Science ®Google Scholar
• MIMORI T, AKIZUKI M, YAMAGATA H, INADA S, YOSHIDA S, HOMMA M: Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis–scleroderma overlap. J. Clin. Invest. (1981) 68:611-620.
   PubMed Web of Science ®Google Scholar
• REEVES WH: Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J. Exp. Med. (1985) 161:18-39.
   PubMed Web of Science ®Google Scholar
• YANEVA M, WEN J, AYALA A, COOK R: cDNA-derived amino acid sequence of the 86-kDa subunit of the Ku antigen. J. Biol. Chem. (1989) 264:13407-13411.
   PubMed Web of Science ®Google Scholar
• COOLEY HM, MELNY BJ, GLEESON R, GRECO T, KAY TWH: Clinical and serological associations of anti-ku antibody. J. Rheumatol. (1999) 263:563-567.
   Google Scholar
• FRANCESCHINI F, CAVAZZANA I, GENERALI D et al.: Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. J. Rheumatol. (2002) 29:1393-1397.
   PubMed Web of Science ®Google Scholar
• TAKEDA Y, DYNAN WS: Autoantibodies against DNA double-strand break repair proteins. Front. Biosci. (2001) 6:D1412-D1422.
   PubMedGoogle Scholar
• REEVES WH: Antibodies to the p70/p80 (Ku) antigens in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. (1992) 18:391-414.
   PubMed Web of Science ®Google Scholar
• SCHILD-POULTER C, SU A, SHIH A et al.: Association of autoantibodies to Ku and DNA repair proteins in connective tissue diseases. Rheumatology (Oxford) (2007) (In Press).
   Google Scholar
• SUWA A, HIRAKATA M, TAKEDA Y et al.: Autoantibodies to DNA-dependent protein kinase – probes for the catalytic subunit. J. Clin. Invest. (1996) 97:1417-1421.
   PubMed Web of Science ®Google Scholar
• SATOH M, AJMANI AK, STOJANOV L et al.: Autoantibodies that stabilize the molecular interaction of Ku antigen with DNA-dependent protein kinase catalytic subunit. Clin. Exp. Immunol. (1996) 105:460-467.
   PubMed Web of Science ®Google Scholar
• FRITZLER MJ, STINTON LM, CHAN EKL: Autoantibodies to cytoplamsic autoantigens in endosomes, exosomes and the Golgi complex. In: From Etiopathogenesis to the Prediction of Autoimmune Diseases: Relevance of Autoantibodies. Conrad K, Chan EKL, Fritzler MJ, Sack U, Shoenfeld Y, Wiik A (Eds), Pabst Science Publishers, Lengerich, Germany (2007):194-209.
   Google Scholar